Chronic Lymphocytic Leukemia

Overview

Chronic lymphocytic leukemia, often called CLL, is a type of blood cancer that affects certain white blood cells called lymphocytes. These cells are part of the immune system and normally help the body fight infections. In CLL, abnormal lymphocytes build up slowly in the blood, bone marrow, lymph nodes, and sometimes the spleen or liver.

CLL usually develops gradually. Many people feel well at the time it is found, and the condition may be discovered during a routine blood test. Because it can progress slowly, some patients do not need immediate treatment and are monitored carefully by a hematology or oncology team. Others may need treatment if the disease becomes more active or causes symptoms.

CLL is different from acute leukemia, which tends to progress quickly. The word “chronic” means that the disease often has a slower course. However, every patient is different, and evaluation by specialists is important to understand the individual situation.

Symptoms

Some people with CLL have no symptoms, especially in the early stages. When symptoms do occur, they may develop gradually and can be mild at first.

• Swollen lymph nodes in the neck, underarms, or groin, usually painless
• Tiredness, weakness, or reduced stamina
• Frequent or repeated infections
• Fever without a clear cause
• Night sweats
• Unexplained weight loss
• A feeling of fullness or discomfort in the upper left side of the abdomen, which may be related to an enlarged spleen
• Easy bruising or bleeding in some cases
• Shortness of breath or paleness if anemia develops

These symptoms can also be caused by many other medical conditions. Having one or more of them does not necessarily mean a person has CLL, but persistent or unexplained symptoms should be assessed by a doctor.

Causes and Risk Factors

The exact cause of CLL is not fully understood. It begins when changes occur in the genetic material of lymphocytes, causing them to grow and survive longer than normal. These abnormal cells may gradually crowd out healthy blood cells and affect immune function.

CLL is not usually linked to lifestyle choices, and it is not contagious. A person cannot catch it from someone else.

Factors that may increase risk

• Age: CLL is more common in older adults.
• Family history: Having a close relative with CLL or certain other blood cancers may increase risk.
• Sex: CLL is diagnosed more often in men than in women.
• Ancestry: It is more common in some populations than others.

Most people with these risk factors will not develop CLL, and some people diagnosed with CLL have no known risk factors. Risk factors help doctors understand patterns, but they do not predict exactly who will develop the disease.

Diagnosis

CLL is often suspected after a blood test shows a high number of lymphocytes. To confirm the diagnosis and understand the disease better, doctors may use several tests.

• Complete blood count: Measures the number of different blood cells, including white blood cells, red blood cells, and platelets.
• Blood smear: Allows specialists to look at blood cells under a microscope.
• Flow cytometry: A laboratory test that identifies specific markers on blood cells and helps confirm whether the abnormal lymphocytes are consistent with CLL.
• Physical examination: Checks for enlarged lymph nodes, spleen, or liver.
• Additional blood tests: May assess organ function, immune system status, and other factors relevant to treatment planning.
• Genetic and molecular tests: May help doctors understand the behavior of the disease and guide treatment decisions.
• Imaging tests: Sometimes used if there are enlarged lymph nodes or symptoms that need further evaluation.

A bone marrow test is not always required for diagnosis, but it may be recommended in selected cases. The diagnostic process also helps doctors stage the disease and decide whether treatment is needed immediately or whether careful monitoring is appropriate.

Treatment Options

Treatment for CLL depends on several factors, including symptoms, blood test results, stage of disease, genetic features of the leukemia cells, overall health, age, and personal preferences. Not every person with CLL needs treatment right away.

Active monitoring

If CLL is early-stage and not causing symptoms or blood count problems, doctors may recommend regular check-ups rather than immediate treatment. This approach is sometimes called watchful waiting or active surveillance. During monitoring, the healthcare team follows blood counts, symptoms, and physical findings over time.

Systemic therapies

When treatment is needed, options may include targeted therapies, immune-based treatments, chemotherapy-based approaches, or combinations of treatments. These therapies are designed to control the growth of CLL cells, improve blood counts, reduce enlarged lymph nodes or spleen, and manage symptoms. The choice of therapy is individualized.

Supportive care

Supportive care is an important part of CLL management. It may include preventing and treating infections, managing anemia or low platelets, monitoring vaccine needs, and addressing fatigue or other symptoms. Because CLL can affect immune function, doctors may give specific advice about infection precautions and routine health checks.

Advanced treatment approaches

In selected situations, more intensive treatments or participation in clinical research may be discussed. These options depend on the patient’s condition, previous treatments, and specialist assessment.

The goal of treatment planning is to choose an approach that matches the medical features of the disease and the patient’s overall health. Patients are encouraged to ask questions and discuss the potential benefits, risks, and follow-up requirements of each option with their care team.

When to See a Doctor

Medical evaluation is recommended if a person has persistent swollen lymph nodes, unexplained tiredness, repeated infections, night sweats, fever without a clear reason, unexplained weight loss, unusual bruising or bleeding, or ongoing abdominal fullness.

People already diagnosed with CLL should contact their healthcare team if symptoms change, infections become more frequent, lymph nodes enlarge noticeably, or new bleeding, shortness of breath, chest discomfort, or severe weakness occurs. Urgent medical care is needed for severe symptoms such as difficulty breathing, uncontrolled bleeding, confusion, or high fever.

Regular follow-up is important for CLL, even when no treatment is currently needed. Ongoing monitoring helps doctors detect changes early and adjust care when necessary.